Log in
Enquire now
‌

Accent Therapeutics

Accent Therapeutics is a RNA-modifying protein inhibitors founded in 2017 by Robert Copeland.

OverviewStructured DataIssuesContributors

Contents

accenttx.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Medicine
Medicine
Healthcare
Healthcare
Internal medicine
Internal medicine
‌
Synthetic chemistry
Biotechnology
Biotechnology
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Cancer
Cancer
...
Location
Lexington, Massachusetts
Lexington, Massachusetts
United States
United States
B2X
B2B
B2B
0
Founder
‌
Robert Copeland
0
Pitchbook URL
pitchbook.com/profiles...228849-13
Number of Employees (Ranges)
11 – 500
Email Address
contactus@accenttx.com
Phone Number
+133997074000
Investors
‌
The Mark Foundation For Cancer Research
DROIA Ventures
DROIA Ventures
The Column Group
The Column Group
Google Ventures
Google Ventures
Atlas Venture
Atlas Venture
AbbVie Ventures
AbbVie Ventures
EcoR1 Capital
EcoR1 Capital
Founded Date
2017
0
Total Funding Amount (USD)
103,000,000
Latest Funding Round Date
April 23, 2020
Latest Funding Type
Series B
Series B
Country
United States
United States

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
63,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Accent Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.